Related Experiment Video
Updated: Oct 26, 2025
Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis
Published on: February 6, 2020
Risk management recommendations and patient acceptance vary with high-risk breast lesions
Anna C Beck1, Sophia L Fu2, Junlin Liao1
1University of Iowa Hospitals and Clinics, Department of Surgery, 1500 JCP, 200 Hawkins Dr, Iowa City, IA 52242, USA.
Introduction:
Lobular carcinoma in situ (LCIS), atypical ductal and lobular hyperplasia (AH) increase breast cancer risk. We examined risk management recommendations (RMR) and acceptance in AH/LCIS.
Methods:
All patients with AH/LCIS on core needle biopsy from 2013 to 2016 at our institution were identified; cancer patients were excluded. Univariate and multivariate analysis examined factors associated with management.
Results:
98 % of patients were evaluated by breast surgeons and 53 % underwent risk model calculation (RC). 77 % had new RMR. RMR of MRI screening (MRI), genetic counselling (GC) and medical oncology (MO) referral were 41 %, 18 %, 77 %, respectively. MRI screening was more likely recommended in those with strong family history (p = 0.01), and high RC (p < 0.001). Uptake of at least one RMR did not occur in 84 % of patients. Use of RC correlated with MO acceptance (p = 0.049).
Conclusions:
Diagnosis of atypia has the potential to change risk management for most, however only 16 % of patients accepted all RMR.
Related Concept Videos
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
01:30Venous Thrombosis IV: Nursing Management